Vorapaxar with or without clopidogrel after non–ST-segment elevation acute coronary syndromes: Results from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome trial
Title:
Vorapaxar with or without clopidogrel after non–ST-segment elevation acute coronary syndromes: Results from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome trial
Author:
Tricoci, Pierluigi Lokhnygina, Yuliya Huang, Zhen Van de Werf, Frans Cornel, Jan H. Chen, Edmond Wallentin, Lars Held, Claes Aylward, Philip E. Moliterno, David J. Jennings, Lisa K. White, Harvey D. Armstrong, Paul W. Harrington, Robert A. Strony, John Mahaffey, Kenneth W.